*/
© Shutterstock
Gail Evans, Technical Trainer at AlphaBiolabs, examines the latest trends in illicit drug use as seen in the laboratory, from designer drugs to ‘unexpected’ substances in a donor’s sample
As a leading provider of drug testing services for FDACs, family solicitors and social workers, we are often asked about trends in illicit drug use; particularly in cases where a lesser-known drug shows up in a drug test, or where a substance is reported in the test results that may not have been disclosed at the time samples were collected.
New Psychoactive Substances – known as designer drugs or, misleadingly, ‘legal highs’ – are man-made, synthetic drugs which are now showing up regularly in the results of drug tests.
These drugs are manufactured to mimic the effects of ‘traditional’ illegal drugs, such as cocaine, ecstasy, and cannabis and are extremely unpredictable due to their potency. Furthermore, they are often designed to get around drug laws, making them easier for people to purchase via ‘legitimate’ channels i.e. online.
Examples of designer drugs include Bath Salts (synthetic cathinones), a group of drugs known for their stimulant effects, Spice (synthetic cannabis), which mimics the effects of tetrahydrocannabinol (THC), and nitazenes.
Nitazanes are a group of powerful synthetic opioids, that can be injected, inhaled, smoked, or swallowed in tablet form, and have begun to flood the UK market, with an increasing number of sample donors testing positive for these substances.
The effects of nitazenes mimic that of opiates and pose an increased risk of overdose due to their potency. In fact, they have already been linked to dozens of fatalities in the UK, with the Advisory Council on the Misuse of Drugs reporting* that over a quarter of cocaine samples and more than half of heroin/diamorphine samples seized were found to contain isotonitazene as an adulterant.
Other trends include the increased use of designer ‘cocktails’ of drugs. One example of this is Calvin Klein or CK which, rather than being a synthetic drug manufactured in the lab, is instead a deadly combination of cocaine and ketamine, designed to amplify the effects of both substances.
The fact that street drugs are sold illegally means that there is rarely any quality control involved in the manufacturing process. So, whether the user is purchasing a powder, pill, herb, or liquid, unscrupulous manufacturers and dealers may have added any number of substances into the mix.
While laboratories may be instructed to test for the presence of a specific substance, analysis can often reveal the presence of other substances that may not have been disclosed by the sample donor at the time samples were collected. This can sometimes cause the sample donor to dispute their test results, where they claim to have unwittingly consumed substances they did not plan to take. We have seen several instances of this, including one example from a sample donor, who we will refer to as Mr X.
Five substances were found to be present in the hair sample of Mr X: THC, cocaine, norcocaine, benzoylecgonine and ketamine. While he did not dispute the other test results, Mr X was adamant he had not taken ketamine and could not fathom why it might have shown up in his results, saying: ‘I haven’t even seen ketamine. I don’t know anyone who uses it, or even how to use it. I would not be able to get it if I tried, I don’t have a horse, and I’m not a vet!’
Other impurities are often found in substances purchased at street level. Examples include opiate alkaloids in heroin (that occur during the manufacturing process), adulterants, which are designed to mimic the effects of the drug purportedly being offered (e.g. caffeine in ecstasy or amphetamines) and diluents used to ‘bulk’ out the product (e.g. sugars like glucose and lactose).
AlphaBiolabs provides court-admissible drug testing direct from our state-of-the-art, UKAS-accredited laboratory; enabling counsel to act as needed.
We test a wide range of biological samples for the presence of drugs and their metabolites, including urine, oral fluid, hair, and nails. We can also test for a variety of drugs beyond our standard panel, including New Psychoactive Substances.
Our nationwide network of professional sample collectors are trained to collect samples under chain of custody, and our test results are accepted by Family Courts, the Ministry of Justice and the Child Maintenance Service.
We also offer free sample collection for legally-instructed drug tests from our 19 walk-in centres, across the UK and Ireland.
* Advisory Council on the Misuse of Drugs; ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazolone opioids
As a leading provider of drug testing services for FDACs, family solicitors and social workers, we are often asked about trends in illicit drug use; particularly in cases where a lesser-known drug shows up in a drug test, or where a substance is reported in the test results that may not have been disclosed at the time samples were collected.
New Psychoactive Substances – known as designer drugs or, misleadingly, ‘legal highs’ – are man-made, synthetic drugs which are now showing up regularly in the results of drug tests.
These drugs are manufactured to mimic the effects of ‘traditional’ illegal drugs, such as cocaine, ecstasy, and cannabis and are extremely unpredictable due to their potency. Furthermore, they are often designed to get around drug laws, making them easier for people to purchase via ‘legitimate’ channels i.e. online.
Examples of designer drugs include Bath Salts (synthetic cathinones), a group of drugs known for their stimulant effects, Spice (synthetic cannabis), which mimics the effects of tetrahydrocannabinol (THC), and nitazenes.
Nitazanes are a group of powerful synthetic opioids, that can be injected, inhaled, smoked, or swallowed in tablet form, and have begun to flood the UK market, with an increasing number of sample donors testing positive for these substances.
The effects of nitazenes mimic that of opiates and pose an increased risk of overdose due to their potency. In fact, they have already been linked to dozens of fatalities in the UK, with the Advisory Council on the Misuse of Drugs reporting* that over a quarter of cocaine samples and more than half of heroin/diamorphine samples seized were found to contain isotonitazene as an adulterant.
Other trends include the increased use of designer ‘cocktails’ of drugs. One example of this is Calvin Klein or CK which, rather than being a synthetic drug manufactured in the lab, is instead a deadly combination of cocaine and ketamine, designed to amplify the effects of both substances.
The fact that street drugs are sold illegally means that there is rarely any quality control involved in the manufacturing process. So, whether the user is purchasing a powder, pill, herb, or liquid, unscrupulous manufacturers and dealers may have added any number of substances into the mix.
While laboratories may be instructed to test for the presence of a specific substance, analysis can often reveal the presence of other substances that may not have been disclosed by the sample donor at the time samples were collected. This can sometimes cause the sample donor to dispute their test results, where they claim to have unwittingly consumed substances they did not plan to take. We have seen several instances of this, including one example from a sample donor, who we will refer to as Mr X.
Five substances were found to be present in the hair sample of Mr X: THC, cocaine, norcocaine, benzoylecgonine and ketamine. While he did not dispute the other test results, Mr X was adamant he had not taken ketamine and could not fathom why it might have shown up in his results, saying: ‘I haven’t even seen ketamine. I don’t know anyone who uses it, or even how to use it. I would not be able to get it if I tried, I don’t have a horse, and I’m not a vet!’
Other impurities are often found in substances purchased at street level. Examples include opiate alkaloids in heroin (that occur during the manufacturing process), adulterants, which are designed to mimic the effects of the drug purportedly being offered (e.g. caffeine in ecstasy or amphetamines) and diluents used to ‘bulk’ out the product (e.g. sugars like glucose and lactose).
AlphaBiolabs provides court-admissible drug testing direct from our state-of-the-art, UKAS-accredited laboratory; enabling counsel to act as needed.
We test a wide range of biological samples for the presence of drugs and their metabolites, including urine, oral fluid, hair, and nails. We can also test for a variety of drugs beyond our standard panel, including New Psychoactive Substances.
Our nationwide network of professional sample collectors are trained to collect samples under chain of custody, and our test results are accepted by Family Courts, the Ministry of Justice and the Child Maintenance Service.
We also offer free sample collection for legally-instructed drug tests from our 19 walk-in centres, across the UK and Ireland.
* Advisory Council on the Misuse of Drugs; ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazolone opioids
Gail Evans, Technical Trainer at AlphaBiolabs, examines the latest trends in illicit drug use as seen in the laboratory, from designer drugs to ‘unexpected’ substances in a donor’s sample
The Chair of the Bar reports back
Clement Cowley, Partner at The Penny Group, explains how global events can influence the performance of pensions and ISAs, and why taking a long-term approach to investing is often the most effective strategy
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, discusses what family law professionals need to know about hallucinogens, from the main hallucinogenic drugs encountered in family proceedings, to their effects and the testing options available
Harmony Christian Ministries is the latest charity to benefit from a £500 donation from AlphaBiolabs via the company’s Giving Back initiative
By David Green
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, examines the forensic science underpinning hair drug testing, its evidential scope and limitations, and why it remains the gold standard for evidencing patterns of drug use in family proceedings
At the start of her term, Chair of the Bar 2026 Kirsty Brimelow KC set out a series of priorities for the year ahead. One of those priorities was children in the justice system
As the world becomes more digital, Barbara Vinagre Mota examines international research into the mental health consequences of judges’ exposure to graphic and immersive evidence, highlighting the importance of support systems
In an era of patient-centred care and growing concern over misconduct in medical settings, why do women still lack the right to choose women consultants for examination and treatment? Charles Davey investigates
Reviewed by Daniel Barnett
James McNeill Whistler at Tate Britain until 27 September Rothko in Florence at Palazzo Strozzi until 23 August Reviewed by Stephen Cragg KC